CAREMAX INC (CMAX)

US14171W2026 - Common Stock

0.4215  -0.15 (-26.22%)

After market: 0.3089 -0.11 (-26.71%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
295.762M631.132M
113.39%
751.102M
19.01%
848.79M
13.01%
1.124B
32.42%
1.281B
13.97%
1.405B
9.68%
1.706B
21.42%
1.956B
14.65%
2.228B
13.91%
2.519B
13.06%
EBITDA
YoY % growth
-14.086M-7.281M
48.31%
-81.057M
-1,013.27%
-43.146M
46.77%
-3.639M
91.57%
47.519M
1,405.70%
45.492M
-4.27%
47.226M
3.81%
47.634M
0.86%
48.348M
1.50%
54.978M
13.71%
EBIT
YoY % growth
-27.301M
-580.48%
-29M
-6.22%
-108.844M
-275.32%
-61.195M
43.78%
-35.756M
41.57%
11.796M
132.99%
-7.752M
-165.72%
-6.426M
17.11%
-4.488M
30.16%
-2.754M
38.64%
4.59M
266.67%
Operating Margin
-9.23%-4.59%-14.49%-7.21%-3.18%0.92%-0.55%-0.38%-0.23%-0.12%0.18%
EPS
YoY % growth
N/A7.20
203.80%
-183.03
-2,642.08%
-29.73
83.76%
-19.60
34.08%
-8.74
55.43%
N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-6.95
74.81%
-6.04
95.15%
-5.42
52.86%
-5.75
41.66%
-5.20
25.24%
-4.54
24.75%
-2.09
61.39%
-1.81
68.62%
-1.35
74.09%
-0.96
78.90%
Revenue
Q2Q % growth
200.01M
-0.91%
195.8M
28.96%
257.3M
10.79%
302.19M
52.14%
283.46M
41.72%
281.08M
43.55%
351.16M
36.48%
379.64M
25.63%
341.5M
20.48%
338.34M
20.37%
EBITDA
Q2Q % growth
-11.64M
-222.54%
-3.947M
92.95%
-1.54M
89.74%
-3.799M
41.85%
-1.184M
89.83%
2.878M
172.92%
8.18M
631.28%
12.23M
421.93%
17.483M
1,576.33%
22.246M
672.97%
EBIT
Q2Q % growth
-12.577M
-17.12%
-20.91M
75.05%
-9.16M
57.80%
-12.107M
38.70%
-9.251M
26.44%
-5.238M
74.95%
2.917M
131.85%
6.538M
154.00%
12.362M
233.62%
17.177M
427.95%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
-9.86
-13.33%
-7.77-2.09-26.86%
Q1 2024
Q2Q % growth
-11.49
48.24%
-8.87-2.62-29.48%
Q4 2023
Q2Q % growth
-124.53
-625.44%
-4.82-119.71-2,482.51%
Q3 2023
Q2Q % growth
-27.60
-268.00%
-3.52-24.08-684.31%
Q2 2023
Q2Q % growth
-8.70
-163.64%
-2.30-6.40-279.08%
Q1 2023
Q2Q % growth
-22.20
-289.47%
-4.44-17.76-400.34%
Q4 2022
Q2Q % growth
23.70
2,075.00%
-1.5325.231,649.02%
Q3 2022
Q2Q % growth
-7.50
-733.33%
-1.96-5.54-282.97%
Q2 2022
Q2Q % growth
-3.30
57.69%
-1.63-1.67-102.22%
Q1 2022
Q2Q % growth
-5.70 -0.77-4.94-645.10%
Q4 2021
Q2Q % growth
-1.20 -1.840.6434.64%
Q3 2021
Q2Q % growth
-0.90 -2.521.6264.35%
Q2 2021
Q2Q % growth
-7.80 -1.22-6.58-537.25%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
198.627M
-11.50%
225.84M-27.213M-12.05%
Q1 2024
Q2Q % growth
232.246M
34.26%
201.18M31.066M15.44%
Q4 2023
Q2Q % growth
151.835M
-7.57%
194.65M-42.815M-22.00%
Q3 2023
Q2Q % growth
201.843M
28.02%
198.42M3.423M1.73%
Q2 2023
Q2Q % growth
224.44M
30.28%
191.87M32.57M16.98%
Q1 2023
Q2Q % growth
172.983M
26.34%
179.5M-6.517M-3.63%
Q4 2022
Q2Q % growth
164.263M
38.85%
152.69M11.573M7.58%
Q3 2022
Q2Q % growth
157.67M
50.71%
143.8M13.87M9.65%
Q2 2022
Q2Q % growth
172.279M
283.53%
138.93M33.349M24.00%
Q1 2022
Q2Q % growth
136.92M
390.44%
133.05M3.87M2.91%
Q4 2021
Q2Q % growth
118.306M 120.81M-2.504M-2.07%
Q3 2021
Q2Q % growth
104.62M 110.45M-5.83M-5.28%
Q2 2021
Q2Q % growth
44.919M 116.83M-71.911M-61.55%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%